Detalles de la búsqueda
1.
Early assessment of tumor response using 18F-FDG PET/CT after one cycle of systemic therapy in patients with recurrent and metastatic breast cancer.
Hell J Nucl Med
; 25(2): 155-162, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35913863
2.
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Ann Surg Oncol
; 26(7): 2175-2183, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941655
3.
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
J Surg Oncol
; 118(1): 228-237, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936704
4.
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
World J Surg Oncol
; 16(1): 26, 2018 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29433529
5.
Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0.
Nagoya J Med Sci
; 80(2): 183-197, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29915436
6.
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
Int J Clin Oncol
; 21(2): 254-261, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338270
7.
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Breast Cancer Res Treat
; 154(3): 521-31, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573829
8.
Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study.
BMC Complement Med Ther
; 23(1): 136, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118716
9.
Relationship between FDG-PET and the immune microenvironment in breast cancer.
Eur J Radiol
; 158: 110661, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542934
10.
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Anticancer Res
; 42(10): 4813-4824, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191999
11.
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Anticancer Res
; 42(10): 4867-4878, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192009
12.
Versican contributes to ligament formation of knee joints.
PLoS One
; 16(4): e0250366, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33886644
13.
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Anticancer Res
; 40(5): 2871-2880, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366437
14.
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.
Anticancer Res
; 40(4): 2141-2150, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234907
15.
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin.
Anticancer Res
; 40(7): 4147-4156, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620664
16.
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Oncotarget
; 11(1): 86-98, 2020 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002126
17.
Colorimetric microbial viability assay based on reduction of water-soluble tetrazolium salts for antimicrobial susceptibility testing and screening of antimicrobial substances.
Anal Biochem
; 393(1): 117-25, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19560434
18.
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Mol Clin Oncol
; 10(2): 275-284, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680208
19.
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
Anticancer Res
; 39(10): 5653-5662, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570463
20.
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.
Sci Rep
; 9(1): 1811, 2019 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30755651